back to top
Search
HomeTagsAPG2449

APG2449

Market

Registrational Section III Research of APG-2449 Cleared by China CDE for the Remedy of Sufferers with NSCLC By Investing.com

ROCKVILLE, Md. and SUZHOU, China, Oct. 7, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a world biopharmaceutical firm engaged in discovering, growing and commercializing therapies...
-
Market

Reside from ASCO 2024 | Ascentage Pharma Releases Up to date Information of FAK/ALK/ROS1 Inhibitor APG-2449 in Sufferers with NSCLC By Investing.com

SUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a worldwide biopharmaceutical firm engaged in creating novel therapies for most...
-

Most Popular

spot_img

our mission is to demystify the complex world of cryptocurrencies and make it accessible to everyone, from beginners to seasoned investors.

2024 DailyMooj. All Rights Reserved.

Latest articles

Popular Categories

2024 DailyMooj. All Rights Reserved.